Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa

Three-year contract leading to advance clinical trials for Lassa Fever vaccines reaffirms Zalgen’s focus on preparedness and its dedication to developing solutions for emerging viral threats Download the French Press Release Oslo, Norway & Germantown, Maryland, August 25, 2021 – Zalgen Labs LLC (Zalgen), a biotechnology and diagnostics company focused on preparedness for high impact, neglected […]

Zalgen Awarded CEPI Contract to Provide Test Kits for Largest Ever Lassa Fever Study in West Africa Read More »